Van Lanschot Kempen Investment Management N.V. Increases Holdings in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Van Lanschot Kempen Investment Management N.V. increased its holdings in Sabra Healthcare REIT by 46.6%, owning approximately 0.16% of the company worth $6.66 million as of the most recent reporting period.
• Several institutional investors, including UMB Bank n.a. and Fifth Third Bancorp, significantly boosted their stakes in Sabra Healthcare REIT during the first quarter of the year.
• Sabra Healthcare REIT recently declared a quarterly dividend of $0.30, representing a 6.3% dividend yield with a payout ratio of 157.89%.

Van Lanschot Kempen Investment Management N.V. lifted its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 46.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 381,329 shares of the real estate investment trust's stock after purchasing an additional 121,158 shares during the quarter. Van Lanschot Kempen Investment Management N.V. owned about 0.16% of Sabra Healthcare REIT worth $6,662,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Northern Trust Corp increased its holdings in shares of Sabra Healthcare REIT by 27.7% in the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock worth $72,214,000 after purchasing an additional 905,466 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Sabra Healthcare REIT by 1.8% in the first quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust's stock worth $71,875,000 after purchasing an additional 74,564 shares during the last quarter. Nuveen LLC bought a new stake in shares of Sabra Healthcare REIT in the first quarter worth about $61,791,000. Janus Henderson Group PLC increased its holdings in shares of Sabra Healthcare REIT by 23.1% in the fourth quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock worth $60,720,000 after purchasing an additional 657,950 shares during the last quarter. Finally, Nuveen Asset Management LLC increased its holdings in shares of Sabra Healthcare REIT by 30.8% in the fourth quarter. Nuveen Asset Management LLC now owns 3,378,733 shares of the real estate investment trust's stock worth $58,520,000 after purchasing an additional 795,902 shares during the last quarter. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Trading Down 0.4%

NASDAQ SBRA traded down $0.07 during trading hours on Friday, hitting $19.55. 3,551,550 shares of the company were exchanged, compared to its average volume of 2,712,781. The stock has a 50-day moving average price of $18.45 and a 200 day moving average price of $17.69. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $20.03. The stock has a market cap of $4.69 billion, a PE ratio of 25.72, a price-to-earnings-growth ratio of 1.56 and a beta of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The firm had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The company's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.1%. Sabra Healthcare REIT's dividend payout ratio is currently 157.89%.

Wall Street Analyst Weigh In

SBRA has been the topic of several analyst reports. Scotiabank boosted their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research note on Monday, June 23rd. JMP Securities boosted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of "Moderate Buy" and a consensus price target of $20.00.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.